Granite Point Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Granite Point Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75,000	Closed	-$1.51M	–	153
2018 Q1	$1.51M	Buy	+75,000	New	+$1.75M	0.15%	46
2015 Q4	–	Sell	-34,190	Closed	-$982K	–	112
2015 Q3	$982K	Buy	34,190 +26,090	+322%	+$1.12M	0.67%	37
2015 Q2	$362K	Sell	8,100 -11,900	-60%	-$448K	0.11%	82
2015 Q1	$692K	Buy	20,000 +10,000	+100%	+$272K	0.25%	63
2014 Q4	$274K	Buy	+10,000	New	+$243K	0.13%	73

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Granite Point Capital Management's DPLO Position: Q2 2018 in Review

Granite Point Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 75,000 shares — an estimated $1.51M sold.

Granite Point Capital Management first reported a position in DPLO in Q4 2014 and held it in 5 quarters. The position peaked at $1.51M in Q1 2018. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

Granite Point Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
Granite Point Capital Management sold 75,000 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $1.51M.
Granite Point Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 5 quarters.
Granite Point Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $1.51M in Q1 2018.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Granite Point Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.